Curcumin as an antiviral agent and immune-inflammatory modulator in COVID-19: A scientometric analysis DOI Creative Commons
Ke Liu, Yi Zhu, X. L. Cao

и другие.

Heliyon, Год журнала: 2023, Номер 9(11), С. e21648 - e21648

Опубликована: Ноя. 1, 2023

Reports regarding the antiviral activity of curcumin have surfaced. However, to date there has been no scientometric analysis relationship between and Coronavirus Disease 2019 (COVID-19). To comprehensively understand studies involving in context COVID-19, we conducted a provide an exhaustive review these studies.We systematically searched Web Science core collection database for bibliographic data indexed from January 1, 2020, December 31, 2022, using keywords such as 'curcumin', 'COVID-19', their synonyms. clarify research content trends related utilized VOSviewer, Origin 2023, Charticulator analysis, supplemented by external data.The final count publications included this study was 252. These originated 63 countries or territories, with India contributing highest number publications. They were published across 170 journals. Notably, Egyptian Knowledge Bank (EKB) emerged most important institution that carried out study. The cited publication had referenced 166 times. main elements involved keyword reflected immuno-inflammatory modulation inflammatory cytokine storm. Furthermore, pharmacological mechanisms treating COVID-19 prominent area research. Simultaneously, exists direct evidence clinical usage enhance outcomes.The underscores burgeoning professional domain curcumin-based treatment COVID-19. Ongoing focused on its immunomodulatory effects storms. On other hand, mechanism is hot spot field at present, which may become trend future. While maintaining focus foundational research, application infection developing parallel, highlighting obvious guiding value practice. insights offer researchers snapshot present state guide further mechanistic validation efforts

Язык: Английский

Angiogenesis and Re-endothelialization in decellularized scaffolds: Recent advances and current challenges in tissue engineering DOI Creative Commons
Radman Mazloomnejad, Amirhesam Babajani, Mohammadreza Kasravi

и другие.

Frontiers in Bioengineering and Biotechnology, Год журнала: 2023, Номер 11

Опубликована: Фев. 16, 2023

Decellularization of tissues and organs has recently become a promising approach in tissue engineering regenerative medicine to circumvent the challenges organ donation complications transplantations. However, one main obstacle reaching this goal is acellular vasculature angiogenesis endothelialization. Achieving an intact functional vascular structure as vital pathway for supplying oxygen nutrients remains decisive challenge decellularization/re-endothelialization procedure. In order better understand overcome issue, complete appropriate knowledge endothelialization its determining variables required. methods their effectiveness, biological mechanical characteristics scaffolds, artificial bioreactors, possible applications, extracellular matrix surface modification, different types utilized cells are factors affecting consequences. This review focuses on how optimize them, well discussing recent developments process re-endothelialization.

Язык: Английский

Процитировано

26

Antimicrobial Activity of Dimeric Flavonoids DOI Creative Commons

Inês Lopes,

Carla Campos,

Rui Medeiros

и другие.

Compounds, Год журнала: 2024, Номер 4(2), С. 214 - 229

Опубликована: Март 22, 2024

Distributed throughout the environment are various microorganisms such as bacteria, fungi, parasites, and viruses. Although many part of human microbiome, pathogenic cause infections ranging from mild to severe. In recent years, identification multidrug-resistant has become a serious public health problem. The resulting call into question therapeutic capacity systems lead approximately 70,000 deaths annually worldwide. progressive resistance antibiotics antifungals been major challenge for medical pharmaceutical community, requiring search new compounds with antimicrobial properties. Several studies have demonstrated potential natural synthesized flavonoids, especially dimers these molecules. this review presented examples dimeric flavonoids that activity against viruses, like influenza Human Immunodeficiency Virus (HIV), protozoal infections, Leishmaniasis Malaria, fungal by Candida albicans Cryptococcus neoformans, bacterial caused, example, Staphylococcus aureus Escherichia coli. pursuit find safe agents therapy in microbial an option not only activity, but also low toxicity usually associated when compared classic antimicrobials.

Язык: Английский

Процитировано

9

Increasing plasma calprotectin (S100A8/A9) is associated with 12-month mortality and unfavourable functional outcome in critically ill COVID-19 patients DOI Creative Commons
Ingrid Didriksson, Maria Lengquist, Martin Spångfors

и другие.

Journal of Intensive Care, Год журнала: 2024, Номер 12(1)

Опубликована: Июль 9, 2024

Abstract Background Calprotectin (S100A8/A9) is a pro-inflammatory mediator primarily released from neutrophils. Previous studies have revealed associations between plasma calprotectin, disease severity and in-hospital mortality in unselected COVID-19 patients. Objective We aimed to assess whether calprotectin dynamics during the first week of intensive care are associated with functional outcome critically ill Methods This prospective study included 498 patients admitted six units (ICUs) Sweden May 2020 2021. Blood samples were collected on ICU admission day 7. The primary was 12-month mortality. Secondary outcomes survivors at 3 12 months, need for invasive mechanical ventilation (IMV) or continuous renal replacement therapy (CRRT) stay. Functional assessed by Glasgow Outcome Scale Extended (GOSE, range 1–8, < 5 representing an unfavourable outcome). Associations examined binary logistic regression analyses adjusted age, sex, BMI, hypertension, smoking, creatinine. Results High 7 independently increased Increasing higher months [OR 2.10 (95% CI 1.18–3.74), p = 0.012], 2.53 1.07–6.10), 0.036], use IMV 2.23 1.10–4.53), 0.027)] CRRT 2.07 1.07–4.00), 0.031)]. A receiver operator characteristic (ROC) model including age good predictor [AUC 0.79 0.74–0.84), 0.001]. Day alone predicted 0.67 0.58–0.76), Conclusion In patients, increasing levels after survivors. Monitoring may be considered evaluate prognosis critical COVID-19. Study registration: ClinicalTrials.gov Identifier : NCT04974775, registered April 28, 2020.

Язык: Английский

Процитировано

5

COVID-19 reduces cardiorespiratory fitness even months after a mild to moderate acute phase: a retrospective cohort study DOI
Ladislav Štěpánek, Marie Nakládalová, Eliška Sovová

и другие.

Infectious Diseases, Год журнала: 2023, Номер 55(10), С. 684 - 693

Опубликована: Июль 3, 2023

Background COVID-19 survivors may experience long-term health problems, including deterioration of cardiorespiratory fitness (CRF), as demonstrated by several cross-sectional studies that compared the results cardiopulmonary exercise tests (CPET) performed only after with predicted values. This study aimed to analyze a change in CRF between repeated CPETs response suffered COVID-19.Methods A total 127 healthcare workers (HCWs; mean age 55.7 years) underwent two interval 762 days. Forty HCWs from (mild moderate severity) interim (321 days before second CPET), and 87 formed control group. Mixed-effects regression multiple adjustment interaction terms was used for variables – maximum oxygen uptake (VO2 max) power output.Results Between both CPETs, VO2 max decreased statistically significantly subgroup (by 3.12 mL/kg/min, p = .034) insignificantly controls 0.56 .412). The proportion achieving 75.9% 59.5% (p .161) survivors, while it increased 73.8% 81% .274) controls. (β −0.66, .014) body mass index −0.49, < .001) were independent negative predictors change. not associated output.Conclusions On basis significantly, albeit rather modestly, reduces almost one year infection. reduction persists even acute phase mild or severity.

Язык: Английский

Процитировано

12

Chronic hyperglycemia impairs anti-microbial function of macrophages in response to Mycobacterium tuberculosis infection DOI
Gaurav Kumar Chaubey, Radheshyam Modanwal, Rahul Dilawari

и другие.

Immunologic Research, Год журнала: 2024, Номер 72(4), С. 644 - 653

Опубликована: Фев. 12, 2024

Язык: Английский

Процитировано

4

COVID-19 and immune dysfunction: Consequences and natural remedies for management DOI

Victoria L. Reed,

Tram M. Ta,

Maryam Khan

и другие.

Elsevier eBooks, Год журнала: 2025, Номер unknown, С. 235 - 264

Опубликована: Янв. 1, 2025

Язык: Английский

Процитировано

0

Post-pandemic insights on COVID-19 and premature ovarian insufficiency DOI Creative Commons
Yaguang Han, Yang Dai, Kexin Wang

и другие.

Open Life Sciences, Год журнала: 2025, Номер 20(1)

Опубликована: Янв. 1, 2025

The COVID-19 pandemic has raised concerns regarding its potential impact on premature ovarian insufficiency (POI). This overview examines the possible interactions between and POI, while also suggesting preventive measures. viral infection's inflammatory response immune dysregulation may adversely affect tissues, leading to inflammation damage. Additionally, alterations in vascular function could impair blood flow hormonal imbalances disrupt normal function. Long-term health effects, such as "long COVID," exacerbate these issues through chronic dysfunction. Public measures, vaccination home isolation, indirectly protect by reducing systemic inflammation. Vaccines mitigate severity of COVID-19's function, isolation reduce stress However, further research is needed validate mechanisms.

Язык: Английский

Процитировано

0

Dissecting the COVID‐19 Immune Response: Unraveling the Pathways of Innate Sensing and Response to SARSCoV‐2 Structural Proteins DOI Open Access
María Guadalupe Vizoso-Pinto, Leonardo de Paula Pereira,

Ana Luiza Pessoa de Mendonça Angelo

и другие.

Journal of Molecular Recognition, Год журнала: 2025, Номер 38(2)

Опубликована: Фев. 5, 2025

ABSTRACT Severe acute respiratory syndrome coronavirus (SARS‐CoV), the virus responsible for COVID‐19, interacts with host immune system through complex mechanisms that significantly influence disease outcomes, affecting both innate and adaptive immunity. These interactions are crucial in determining disease's severity host's ability to clear virus. Given virus's substantial socioeconomic impact, high morbidity mortality rates, public health importance, understanding these is essential. This article examines diverse responses triggered by SARS‐CoV‐2's structural proteins, including spike (S), membrane (M), envelope (E), nucleocapsid (N) along nonstructural proteins (NSPs) open reading frames. play pivotal roles modulation, facilitating viral replication, evading detection, contributing severe inflammatory such as cytokine storms distress (ARDS). The employs strategies like suppressing type I interferon production disrupting key antiviral pathways, MAVS, OAS‐RNase‐L, PKR. study also explores pathways govern activation suppression of throughout COVID‐19. By analyzing sensing receptors initiated upon recognizing SARS‐CoV‐2 this review elucidates associated response Understanding offers valuable insights therapeutic interventions informs strategies, a deeper COVID‐19 immunopathogenesis.

Язык: Английский

Процитировано

0

COVID-19 beyond the lungs: Unraveling its vascular impact and cardiovascular complications—mechanisms and therapeutic implications DOI Creative Commons
Ishita Saha, Oly Banerjee, Shampa Sarkar

и другие.

Science Progress, Год журнала: 2025, Номер 108(1)

Опубликована: Янв. 1, 2025

COVID-19, caused by severe acute respiratory syndrome corona virus 2 (SARS-CoV-2), is primarily a illness but significantly affects the cardiovascular system as well. After entering body through tract, directly and indirectly disrupts vascular system. Vascular endothelial cells (ECs), which express ACE2 TMPRSS2, are targets for viral invasion. However, predominant cause of widespread damage “cytokine storm” induced immune response. This leads to EC activation, inflammation, neutrophil neutrophil–platelet aggregation, causing injury. Additionally, increased expression plasminogen activator inhibitor-1 balance between prothrombotic fibrinolytic processes, while activation renin–angiotensin–aldosterone adds oxidative stress endothelium. In heart, SARS-CoV-2 invades ECs, leading apoptosis pyroptosis, exacerbated inflammation elevated catecholamines. These factors contribute arrhythmias, strokes, myocardial infarction in cases COVID-19. narrative review aims explore mechanisms highlight resulting complications. It also identifies research gaps discusses potential therapeutic strategies mitigate impacts

Язык: Английский

Процитировано

0

The immuno-metabolic trade-off: a driver of metabolic disorders and aging DOI
Juanhong Liu, Q. Sue Huang, Feng Liu

и другие.

Science China Life Sciences, Год журнала: 2025, Номер unknown

Опубликована: Март 17, 2025

Язык: Английский

Процитировано

0